* TuHURA Biosciences Inc HURA.OQ HURA.O is expected
to report
resultson February 12 (estimated) for the period ending December
31 2024
*
* LSEG's mean analyst estimate for TuHURA Biosciences Inc
is for
a loss of 13 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for TuHURA
Biosciences Inc is $12.13, above its last closing price
of $4.27.
This summary was machine generated February 10 at 11:17 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)